CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Hackensack MeridianHealth

Patrick Young, President of Population Health

3 Elements for Advancing Population Health Strategies

Patrick Young

Patrick Young

Biopharma Market Integrator

As hospitals and health systems prepare for the future coming out of COVID-19, population health should be part of every organization’s strategy. Having been on both the provider and payer side of healthcare for more than 20 years, I’m bullish on the need to move to whole person care. At Hackensack MeridianHealth (HMH) our population health strategy is focused on providing patients the right care, at the right time, and in the right place. If we execute that approach successfully, we ultimately improve our patient’s quality of care and the life while lowering medical costs.


Controlling more of the premium dollar


It is essential for provider organizations to develop a viable financial strategy that enables greater control of thepremium dollar through collaborative win-win contracts. This can range from taking on downside risk in payer contracts to owning your own health plan. At HMH, we recognize that most of our revenue comes from fee-for-service and shared savings arrangements today, but we are on a path to take on more value-based contracts and shared risk in the near future. As care moves out of the inpatient setting, we must be prepared to support the patient’s entire journey while managing quality and costs.


Clinical and operational transformation


Clinical transformation is essential to enable our providers to deliver the highest quality care while managing medical costs. Our clinically integrated network, Hackensack Meridian Health Partners, is our organized physician network with approximately 4,600 participating physicians serving more than 371,000 at-risk lives. We needed to establish the right operating model for us to be effective in driving system and practice change. So we partnered with Lumeris to implement an effective leadership and governance model, appropriate value-based physician compensation models, and physician scorecards to communicate performance transparently and encourage best practice sharing.


Simultaneously, our care transformation strategy embraces caring for the patient across the continuum. With our centralized care coordination staff, coupled with practice transformation efforts leveraging both HMH and Lumeris in-market resources, we can better follow the patient journey and ensure the right care. In addition, we are piloting a community health program to tackle social determinants of health and drive whole-person care.


The right technology to enable your population health strategy


Data is only useful if you make it credible and actionable. Like many other hospitals and systems, we have numerous data feeds and tools across our system, and we must ensure that the information can drive better care. Our work with Cerner and Lumeris, through their Maestro™ collaboration, is helping us do just that. We integrate EHR (including data from Epic and others), claims, lab, pharmacy and other relevant data from soon to be more than 100 clinical data sources, into our central data warehouse in Cerner’s HealtheIntentSM for aggregation and normalization. Then we push predictive analytics and actionable insights from Lumeris into our Epic EHR platform where it’s easily accessed by our care team. The care team leverages this data, with the support of Lumeris, to identify patients with rising risk and open care gaps in need of the right interventions.


With this holistic approach to value-based care—a progressive risk contracting strategy, focused clinical transformation, and the right technology infrastructure and operating model—we can capture the full picture of our patients and take action across the entire population.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Market access has become a decisive inflection point where clinical innovation is ultimately validated or stalled within the healthcare ecosystem. This perspective underscores how alignment between clinical development, pricing frameworks and stakeholder engagement is reshaping how value is defined and delivered in biopharma.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/3-elements-for-advancing-population-health-strategies-nwid-2917.html